RJFSA
PPH icon

Raymond James Financial Services Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Raymond James Financial Services Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.64M Sell
17,268
-1,146
-6% -$109K ﹤0.01% 1855
2024
Q2 		$1.68M Buy
18,414
+628
+4% +$56.1K ﹤0.01% 1774
2024
Q1 		$1.61M Sell
17,786
-362
-2% -$31.7K ﹤0.01% 1757
2023
Q4 		$1.48M Buy
18,148
+14,921
+462% +$1.17M ﹤0.01% 1742
2023
Q3 		$258K Sell
3,227
-83
-3% -$6.69K ﹤0.01% 2767
2023
Q2 		$261K Buy
3,310
+548
+20% +$42.9K ﹤0.01% 2758
2023
Q1 		$214K Sell
2,762
-19,602
-88% -$1.51M ﹤0.01% 2860
2022
Q4 		$1.74M Buy
22,364
+19,106
+586% +$1.41M ﹤0.01% 1515
2022
Q3 		$219K Sell
3,258
-68
-2% -$5.01K ﹤0.01% 2796
2022
Q2 		$256K Sell
3,326
-145
-4% -$11.3K ﹤0.01% 2703
2022
Q1 		$277K Buy
3,471
+167
+5% +$12.8K ﹤0.01% 2765
2021
Q4 		$254K Buy
3,304
+23
+0.7% +$1.71K ﹤0.01% 2817
2021
Q3 		$239K Buy
3,281
+464
+16% +$34.6K ﹤0.01% 2853
2021
Q2 		$206K Buy
+2,817
New +$201K ﹤0.01% 2999
2018
Q2 		– Sell
-4,220
Closed -$240K – 2844
2018
Q1 		$240K Sell
4,220
-1,672
-28% -$99.9K ﹤0.01% 2151
2017
Q4 		$350K Buy
5,892
+71
+1% +$4.07K ﹤0.01% 1931
2017
Q3 		$336K Sell
5,821
-42,791
-88% -$2.43M ﹤0.01% 1962
2017
Q2 		$2.87M Buy
48,612
+42,944
+758% +$2.43M 0.02% 723
2017
Q1 		$313K Buy
+5,668
New +$307K ﹤0.01% 1872
2016
Q3 		– Sell
-35,335
Closed -$2.07M – 2371
2016
Q2 		$2.07M Buy
+35,335
New +$2.06M 0.02% 714

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPGK
Financial Partners Group (Kansas) Overland Park, Kansas $836M AUM 21.04% 1-Year Est. Return

Raymond James Financial Services Advisors's PPH Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its VanEck Pharmaceutical ETF (PPH) stake by 6.2% in Q3 2024, selling an estimated $109K and leaving 17,268 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Raymond James Financial Services Advisors first reported a position in PPH in Q2 2016 and has held it in 20 quarters since. The position peaked at $2.87M in Q2 2017. 142 funds tracked by Wall St. Rank hold PPH as of Q3 2024.

  • Raymond James Financial Services Advisors held 17,268 shares of VanEck Pharmaceutical ETF worth $1.64M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 1,146 VanEck Pharmaceutical ETF shares in Q3 2024, an estimated $109K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1855 holding.
  • Raymond James Financial Services Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2016 and has held it in 20 quarters since.
  • Raymond James Financial Services Advisors's VanEck Pharmaceutical ETF position peaked at $2.87M in Q2 2017.
  • 142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.